SI9300244A - Novi kinazolini kot inhibitorji HIV reverzne transkriptaze - Google Patents
Novi kinazolini kot inhibitorji HIV reverzne transkriptaze Download PDFInfo
- Publication number
- SI9300244A SI9300244A SI9300244A SI9300244A SI9300244A SI 9300244 A SI9300244 A SI 9300244A SI 9300244 A SI9300244 A SI 9300244A SI 9300244 A SI9300244 A SI 9300244A SI 9300244 A SI9300244 A SI 9300244A
- Authority
- SI
- Slovenia
- Prior art keywords
- chloro
- cyclopropyl
- dihydro
- quinazolin
- pyridyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88011992A | 1992-05-07 | 1992-05-07 | |
| US99116492A | 1992-12-16 | 1992-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300244A true SI9300244A (sl) | 1993-12-31 |
Family
ID=27128564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9300244A SI9300244A (sl) | 1992-05-07 | 1993-05-07 | Novi kinazolini kot inhibitorji HIV reverzne transkriptaze |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP0639184A1 (fi) |
| JP (1) | JPH0813805B2 (fi) |
| KR (1) | KR950701322A (fi) |
| CN (1) | CN1085550A (fi) |
| AU (2) | AU4220493A (fi) |
| BG (1) | BG99149A (fi) |
| CA (1) | CA2095194A1 (fi) |
| CZ (1) | CZ272494A3 (fi) |
| FI (1) | FI945199A (fi) |
| HR (1) | HRP930857A2 (fi) |
| HU (1) | HUT71401A (fi) |
| IL (1) | IL105551A0 (fi) |
| MX (1) | MX9302681A (fi) |
| SI (1) | SI9300244A (fi) |
| WO (1) | WO1993022292A1 (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2281297A (en) * | 1993-08-27 | 1995-03-01 | Merck & Co Inc | Quinazoline compounds |
| US5434152A (en) * | 1993-11-08 | 1995-07-18 | Merck & Co., Inc. | Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone |
| HRP980143A2 (en) * | 1997-04-09 | 1999-02-28 | Soo Sung Ko | 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| US6124302A (en) * | 1997-04-09 | 2000-09-26 | Dupont Pharmaceuticals | 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
| WO2000000475A1 (en) * | 1998-06-30 | 2000-01-06 | Du Pont Pharmaceuticals Company | Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| CA2370141A1 (en) | 1999-05-26 | 2000-12-07 | James D. Rodgers | 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| JP2003531894A (ja) * | 2000-04-25 | 2003-10-28 | サムスン エレクトロニクス カンパニー リミテッド | マトリックスメタロプロテアーゼ阻害剤としてのビフェニルブチル酸誘導体 |
| US7119111B2 (en) * | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| AU2008308092B2 (en) * | 2007-10-05 | 2013-07-11 | Msd K.K. | Benzoxazinone derivative |
| CN101544630B (zh) * | 2009-05-13 | 2013-03-13 | 中国科学院广州生物医药与健康研究院 | 羟基化茚地那韦的制备方法 |
| WO2017003724A1 (en) | 2015-07-01 | 2017-01-05 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US11028068B2 (en) | 2017-07-25 | 2021-06-08 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL147140B (nl) * | 1968-11-26 | 1975-09-15 | Farmaceutici Italia | Werkwijze voor het bereiden van geneesmiddelen met een remmende werking op het centrale zenuwstelsel. |
| IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
-
1993
- 1993-04-28 AU AU42204/93A patent/AU4220493A/en not_active Abandoned
- 1993-04-28 EP EP93910860A patent/EP0639184A1/en not_active Withdrawn
- 1993-04-28 WO PCT/US1993/003975 patent/WO1993022292A1/en not_active Application Discontinuation
- 1993-04-28 HU HU9403187A patent/HUT71401A/hu unknown
- 1993-04-28 CZ CZ942724A patent/CZ272494A3/cs unknown
- 1993-04-28 KR KR1019940703948A patent/KR950701322A/ko not_active Application Discontinuation
- 1993-04-29 CA CA002095194A patent/CA2095194A1/en not_active Abandoned
- 1993-04-29 IL IL105551A patent/IL105551A0/xx unknown
- 1993-04-29 EP EP93201232A patent/EP0569083A1/en not_active Withdrawn
- 1993-05-05 HR HR930857A patent/HRP930857A2/hr not_active Application Discontinuation
- 1993-05-06 CN CN93107074A patent/CN1085550A/zh active Pending
- 1993-05-06 MX MX9302681A patent/MX9302681A/es unknown
- 1993-05-06 AU AU38413/93A patent/AU3841393A/en not_active Abandoned
- 1993-05-07 SI SI9300244A patent/SI9300244A/sl unknown
- 1993-05-07 JP JP5107015A patent/JPH0813805B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-31 BG BG99149A patent/BG99149A/xx unknown
- 1994-11-04 FI FI945199A patent/FI945199A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993022292A1 (en) | 1993-11-11 |
| AU3841393A (en) | 1993-11-11 |
| CZ272494A3 (en) | 1995-10-18 |
| FI945199A0 (fi) | 1994-11-04 |
| MX9302681A (es) | 1994-05-31 |
| CA2095194A1 (en) | 1993-11-08 |
| AU4220493A (en) | 1993-11-29 |
| KR950701322A (ko) | 1995-03-23 |
| EP0639184A1 (en) | 1995-02-22 |
| CN1085550A (zh) | 1994-04-20 |
| FI945199A (fi) | 1994-11-04 |
| HRP930857A2 (en) | 1995-06-30 |
| JPH069578A (ja) | 1994-01-18 |
| HUT71401A (en) | 1995-11-28 |
| BG99149A (en) | 1995-06-30 |
| EP0569083A1 (en) | 1993-11-10 |
| IL105551A0 (en) | 1993-08-18 |
| JPH0813805B2 (ja) | 1996-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1995012583A1 (en) | New quinazolines as inhibitors of hiv reverse transcriptase | |
| AU676563B2 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| JP4625838B2 (ja) | Ｈｉｖインテグラーゼ阻害薬 | |
| EP0766674B1 (en) | New hiv protease inhibitors | |
| EP0617968B1 (en) | HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS | |
| US5807841A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| JP2008537741A (ja) | Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびそれらの使用 | |
| KR20010075268A (ko) | 시아노페닐 유도체 | |
| PL175615B1 (pl) | Benzoksazynony będące inhibitorami odwrotnej transkryptazy HIV, zawierające je środki farmaceutyczne oraz sposób wytwarzania (-)-6-chloro-4-cyklopropyloetynylo-4-trifluorometylo-1,4-dihydro-2H-3,1-benzoksazyn-2-onu | |
| SI9300244A (sl) | Novi kinazolini kot inhibitorji HIV reverzne transkriptaze | |
| WO1998042666A1 (en) | Novel 3,4-dialkoxyphenyl derivatives and the use thereof | |
| US5846978A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| GB2271566A (en) | HIV integrase inhibitors | |
| US5650412A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| CA2269135A1 (en) | Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase | |
| US5939414A (en) | Benzodiazepine hydrazide derivatives as inhibitors of HIV integrase | |
| DE68906617T2 (de) | Substituierte 5,6,7,8-tetrahydroimidazo(1,5-a)pyridine und verfahren zu ihrer herstellung. | |
| CA2252915A1 (en) | Hiv protease inhibitors useful for the treatment of aids |